ArticleFrontiers in immunology2026
Crosstalk between
Article in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Introduction: Methods: Using a murine model, we studied SARS-CoV-2 superinfection during acute and chronic stages of high dose tuberculosis (TB). Results: In acute TB, coinfection increased mortality associated with higher brain viral loads. During chronic TB, survival improved slightly without affecting brain infection. Interestingly, histopathology showed disorganized inflammatory responses in co-infected mice versus granuloma-like structures in TB alone. Spatial transcriptomics revealed expanded B cell populations and upregulation of immunoglobulin-associated genes, as well as an absence of distinct Tcell clusters, consistent with a relative prominence of humoral immune signatures in chronic TB. Notably, SARS-CoV-2 infection produced bronchial inflammation dominated by innate immune cells, like acute TB but unlike the infiltration of foamy macrophage during chronic TB. Discussion: Overall, SARS-CoV-2 coinfection was associated with a distinct pulmonary immune landscape compared to TB alone, including differences in macrophage and lymphocyte composition and spatial organization, suggesting that coinfection may modulate the local immune response to TB and highlighting the need for further investigation into the development of vaccines and therapies targeting both pathogens.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.